Logo image of CRON

CRONOS GROUP INC (CRON) Stock Price, Quote, News and Overview

NASDAQ:CRON - Nasdaq - CA22717L1013 - Common Stock - Currency: USD

1.97  +0.03 (+1.55%)

After market: 1.98 +0.01 (+0.51%)

CRON Quote, Performance and Key Statistics

CRONOS GROUP INC

NASDAQ:CRON (2/21/2025, 9:09:18 PM)

After market: 1.98 +0.01 (+0.51%)

1.97

+0.03 (+1.55%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High3.14
52 Week Low1.83
Market Cap753.58M
Shares382.53M
Float200.48M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PE289.56
Earnings (Next)03-04 2025-03-04/amc
IPO05-07 2014-05-07


CRON short term performance overview.The bars show the price performance of CRON in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -5 -10 -15

CRON long term performance overview.The bars show the price performance of CRON in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40

The current stock price of CRON is 1.97 USD. In the past month the price increased by 2.07%. In the past year, price decreased by -11.66%.

CRONOS GROUP INC / CRON Daily stock chart

CRON Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 67.21 829.40B
NVO NOVO-NORDISK A/S-SPONS ADR 27.53 390.99B
JNJ JOHNSON & JOHNSON 16.25 390.76B
AZN ASTRAZENECA PLC-SPONS ADR 20.56 230.17B
MRK MERCK & CO. INC. 11.71 226.40B
NVS NOVARTIS AG-SPONSORED ADR 13.77 215.98B
PFE PFIZER INC 8.46 149.04B
SNY SANOFI-ADR 13.62 136.54B
BMY BRISTOL-MYERS SQUIBB CO 48.97 113.23B
GSK GSK PLC-SPON ADR 7.81 74.77B
ZTS ZOETIS INC 27.1 72.39B
TAK TAKEDA PHARMACEUTIC-SP ADR 31.95 44.58B

About CRON

Company Profile

CRON logo image Cronos Group, Inc. engages in the production and distribution of cannabis. The company is headquartered in Toronto, Ontario. The company went IPO on 2014-05-07. The firm operates through one segment, which is comprised of operations in Canada and Israel and is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Company’s international brand portfolio includes Spinach, PEACE NATURALS, and Lord Jones. The Spinach brand offers pre-rolls infused with cold-filtered cannabis extract and coated in kief, and all-in-one disposable vapes. The Lord Jones is a hemp-derived cannabidiol (CBD) brand. Its Lord Jones Hash Fusions are a line-up of premium ice water hash infused pre-rolls. This brand also offers vapes and edibles. Its PEACE NATURALS offer Peppermint CBD, a blend of CBD extract, quality medium-chain triglycerides (MCT) oil, and a hint of natural peppermint flavor.

Company Info

CRONOS GROUP INC

4491 Concession Rd 12

TORONTO ONTARIO M5V 2H1 CA

CEO: Kurt Schmidt

Employees: 356

Company Website: https://thecronosgroup.com/

Investor Relations: https://ir.thecronosgroup.com/

Phone: 14165040004

CRONOS GROUP INC / CRON FAQ

What is the stock price of CRONOS GROUP INC today?

The current stock price of CRON is 1.97 USD. The price increased by 1.55% in the last trading session.


What is the ticker symbol for CRONOS GROUP INC stock?

The exchange symbol of CRONOS GROUP INC is CRON and it is listed on the Nasdaq exchange.


On which exchange is CRON stock listed?

CRON stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for CRONOS GROUP INC stock?

11 analysts have analysed CRON and the average price target is 2.56 USD. This implies a price increase of 29.73% is expected in the next year compared to the current price of 1.97. Check the CRONOS GROUP INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is CRONOS GROUP INC worth?

CRONOS GROUP INC (CRON) has a market capitalization of 753.58M USD. This makes CRON a Small Cap stock.


How many employees does CRONOS GROUP INC have?

CRONOS GROUP INC (CRON) currently has 356 employees.


What are the support and resistance levels for CRONOS GROUP INC (CRON) stock?

CRONOS GROUP INC (CRON) has a support level at 1.96 and a resistance level at 1.98. Check the full technical report for a detailed analysis of CRON support and resistance levels.


Is CRONOS GROUP INC (CRON) expected to grow?

The Revenue of CRONOS GROUP INC (CRON) is expected to grow by 38.35% in the next year. Check the estimates tab for more information on the CRON EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy CRONOS GROUP INC (CRON) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does CRONOS GROUP INC (CRON) stock pay dividends?

CRON does not pay a dividend.


When does CRONOS GROUP INC (CRON) report earnings?

CRONOS GROUP INC (CRON) will report earnings on 2025-03-04, after the market close.


What is the Price/Earnings (PE) ratio of CRONOS GROUP INC (CRON)?

CRONOS GROUP INC (CRON) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.06).


What is the Short Interest ratio of CRONOS GROUP INC (CRON) stock?

The outstanding short interest for CRONOS GROUP INC (CRON) is 1.88% of its float. Check the ownership tab for more information on the CRON short interest.


CRON Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to CRON. When comparing the yearly performance of all stocks, CRON is a bad performer in the overall market: 75.58% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

CRON Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to CRON. While CRON has a great health rating, there are worries on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CRON Financial Highlights

Over the last trailing twelve months CRON reported a non-GAAP Earnings per Share(EPS) of -0.06. The EPS increased by 77.78% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -4.01%
ROE -4.39%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%663.28%
Sales Q2Q%38.11%
EPS 1Y (TTM)77.78%
Revenue 1Y (TTM)28.05%

CRON Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 75% to CRON. The Buy consensus is the average rating of analysts ratings from 11 analysts.

For the next year, analysts expect an EPS growth of 7.27% and a revenue growth 38.35% for CRON


Ownership
Inst Owners14.79%
Ins Owners5.46%
Short Float %1.88%
Short Ratio2.54
Analysts
Analysts74.55
Price Target2.56 (29.95%)
EPS Next Y7.27%
Revenue Next Year38.35%